Connecting families with 5p- Syndrome to research opportunities, clinical trials, and the scientists working to better understand this condition. Every participant matters.
5p- Syndrome research has advanced considerably since the condition was first described, but significant questions remain unanswered.
Early studies focused on documenting the characteristics of 5p- and the family environment. Researchers established that intensive early intervention — particularly in speech and language — produced significantly better outcomes. These foundational studies shaped current therapeutic approaches.
Researchers also identified that children with 5p- who received consistent, enriched home environments showed greater developmental progress, underscoring the critical role families play.
High-resolution chromosomal microarray technology has enabled researchers to precisely map deletion boundaries and correlate them with clinical features. Studies have identified critical regions on chromosome 5p — particularly the CTNND2 gene region — associated with more severe intellectual disability.
Patient registries have become critical tools, allowing researchers to aggregate data from the relatively small global 5p- population to identify patterns that would be impossible to see in a single clinical setting.
Many important questions remain open. Researchers are actively studying why individuals with similar deletion sizes can have dramatically different outcomes, the neurological basis of the characteristic cry, and the optimal timing and intensity of early interventions.
Long-term outcomes in adulthood — quality of life, community integration, health trajectory — are understudied. This is an area where adult participants and their families are urgently needed.
With fewer than 50,000 people estimated to have 5p- Syndrome worldwide, every family who participates in research makes a meaningful difference.
Registries collect demographic and clinical information from families, creating the large datasets researchers need to identify patterns. Registration is typically low-burden — a survey completed once with occasional updates. The Five P- Society maintains a research registry.
Biobanks store biological samples — blood, saliva, tissue — for future research use. Genetic material from individuals with 5p- is especially valuable for understanding deletion mechanisms and gene function. Participation typically involves a one-time sample collection, often done at home.
Many important research questions can be answered through parent-reported surveys about development, behavior, medical history, and quality of life. Survey studies are among the easiest ways to contribute — they can be completed online from home and typically take 20–60 minutes.
Clinical trials test interventions — therapies, medications, educational approaches — to determine safety and effectiveness. Participating in a trial is a significant commitment, but it gives families access to cutting-edge treatments and contributes directly to evidence-based care standards for future generations.
ClinicalTrials.gov is the official U.S. registry for clinical studies. It lists trials currently recruiting, as well as completed and ongoing studies. Here's how to use it effectively for 5p- Syndrome.
Try "5p- syndrome," "cri du chat," or "chromosome 5p deletion." Broad searches often return more results.
Select "Recruiting" to see studies that are actively enrolling participants. "Not yet recruiting" studies may open soon.
Each trial lists inclusion and exclusion criteria — age ranges, deletion size, prior treatments. Read these before contacting a study team.
Each listing has a primary contact. Coordinators expect questions — ask about travel reimbursement, time commitment, and what participation involves before committing.
The Five P- Society actively collaborates with academic medical centers and research institutions to facilitate family participation and fund scientific inquiry.
Investigating genotype-phenotype correlations in 5p- Syndrome with a focus on understanding why deletion size and location predict certain outcomes more reliably than others. Currently recruiting participants for a longitudinal cohort study.
A multi-year study examining quality of life, community integration, and health outcomes in adults (18+) with 5p- Syndrome. This is one of the first systematic studies of adult outcomes in this population. Enrollment ongoing through 2027.
Conducting a randomized controlled trial of two AAC intervention approaches for minimally verbal children with 5p- Syndrome ages 3–8. Participants receive 16 weeks of intervention at no cost. Remote participation options available.
5p- Syndrome results from a deletion on the short arm of chromosome 5. The size and location of that deletion varies significantly between individuals — and that variation has real consequences.
Smaller deletions, confined to the distal portion of 5p, are typically associated with milder intellectual disability and the characteristic high-pitched cry (caused by deletion in the 5p15.3 region). Many individuals with small deletions develop meaningful verbal communication and relative independence.
Larger deletions extending toward the centromere (proximal 5p) are associated with more significant intellectual disability and greater medical complexity. The CTNND2 gene in the 5p15.2 region is thought to be particularly important — its deletion correlates with more severe cognitive involvement.
About 10–15% of 5p- cases involve a translocation, where deleted chromosomal material is attached to another chromosome. Translocation cases can have additional genetic material that modifies the phenotype. Knowing whether a deletion is simple or involves translocation affects recurrence risk counseling for parents.
Researchers are working to understand precisely which deleted genes drive which features. This is challenging because genes interact with each other and with environmental factors. However, better genotype-phenotype maps will eventually allow clinicians to offer more individualized prognoses and targeted interventions.
Even with precise deletion mapping, individual outcomes vary widely. Two children with nearly identical deletions may have very different developmental trajectories. This reflects the complex interaction of genetics, early intervention, family environment, and factors not yet identified. Deletion size provides a range of probabilities — not a fixed destiny.
Legitimate research follows strict ethical standards. Here is what you need to know before participating in any study.
Every legitimate research study involving human participants must be reviewed and approved by an Institutional Review Board (IRB). The IRB is an independent committee that evaluates whether a study's risks are justified and whether participants' rights are protected. Ask any researcher: "What IRB approved this study, and what is the protocol number?"
Before participating, you must receive a written informed consent document explaining the study's purpose, procedures, risks, benefits, and your right to withdraw at any time without penalty. For children, you will sign as the parent or guardian. Take time to read it fully — ask questions about anything unclear before signing.
Ask how your data will be stored, who will have access, whether it will be shared with other researchers, and whether it will be de-identified. Reputable studies follow HIPAA requirements and have clear data management protocols. You can ask to see the data sharing policy in writing.
No. Informed consent is ongoing, not a one-time commitment. You can withdraw from any study at any time, for any reason, without penalty or loss of care. Some studies are one-time (a single survey or blood draw), while others involve multiple visits over months or years. The consent document will clearly describe the time commitment — ask for clarification if it is not clear.
Yes. Many studies specifically need participants with significant communication challenges, including minimally verbal individuals. Parent-proxy reporting is standard practice — you provide information about your child's functioning, history, and behaviors. Some studies also involve direct observation or non-verbal tasks rather than verbal assessments.
It depends on the type of study. Observational studies and registries typically offer no direct benefit to participants — you contribute data that benefits the broader community. Intervention studies (clinical trials) may offer direct benefit if the intervention being tested is effective, though this is not guaranteed. Some studies offer access to genetic information or clinical assessments that families find valuable even apart from the research context.
The Society evaluates research partnerships based on scientific merit, IRB approval, relevance to the 5p- community's priorities, and the researchers' track record of family-centered engagement. We prioritize research that addresses the questions our families say matter most, and we require that participating researchers share results with the community in accessible language. Contact our research liaison at research@fivepminus.org to propose a partnership.
Register for our research newsletter to receive updates on new studies, findings from ongoing research, and opportunities to participate — delivered directly to your inbox.